Articles with public access mandates - Benet lzLearn more
Not available anywhere: 3
Age and sex differences in the effects of the immunosuppressants cyclosporine, sirolimus and everolimus on rat brain metabolism
S Gottschalk, CL Cummins, D Leibfritz, U Christians, LZ Benet, ...
Neurotoxicology 32 (1), 50-57, 2011
Mandates: German Research Foundation
Differential effects of fibrates on the metabolic activation of 2-phenylpropionic acid in rats
C Li, MP Grillo, I Badagnani, KL Fife, LZ Benet
Drug metabolism and disposition 36 (4), 682-687, 2008
Mandates: US National Institutes of Health
Batch Selection via In Vitro/In Vivo Correlation in Pharmacokinetic Bioequivalence Testing
E Burmeister Getz, KJ Carroll, J Mielke, B Jones, LZ Benet
AAPS PharmSciTech 22 (7), 224, 2021
Mandates: European Commission
Available somewhere: 100
Membrane transporters in drug development
Nature reviews Drug discovery 9 (3), 215-236, 2010
Mandates: US National Institutes of Health
BDDCS, the Rule of 5 and drugability
LZ Benet, CM Hosey, O Ursu, TI Oprea
Advanced drug delivery reviews 101, 89-98, 2016
Mandates: US National Institutes of Health
BDDCS applied to over 900 drugs
LZ Benet, F Broccatelli, TI Oprea
The AAPS journal 13, 519-547, 2011
Mandates: US National Institutes of Health
The role of transporters in the pharmacokinetics of orally administered drugs
S Shugarts, LZ Benet
Pharmaceutical research 26, 2039-2054, 2009
Mandates: US National Institutes of Health
The role of BCS (biopharmaceutics classification system) and BDDCS (biopharmaceutics drug disposition classification system) in drug development
LZ Benet
Journal of pharmaceutical sciences 102 (1), 34-42, 2013
Mandates: US National Institutes of Health
Mouse liver repopulation with hepatocytes generated from human fibroblasts
S Zhu, M Rezvani, J Harbell, AN Mattis, AR Wolfe, LZ Benet, ...
Nature 508 (7494), 93-97, 2014
Mandates: US National Institutes of Health
The drug transporter− metabolism alliance: uncovering and defining the interplay
LZ Benet
Molecular pharmaceutics 6 (6), 1631-1643, 2009
Mandates: US National Institutes of Health
Current recommended dosing of vancomycin for children with invasive methicillin-resistant Staphylococcus aureus infections is inadequate
A Frymoyer, AL Hersh, LZ Benet, BJ Guglielmo
The Pediatric infectious disease journal 28 (5), 398-402, 2009
Mandates: US National Institutes of Health
Effects of drug transporters on volume of distribution
A Grover, LZ Benet
The AAPS journal 11, 250-261, 2009
Mandates: US National Institutes of Health
Drug Discovery and Regulatory Considerations for Improving In Silico and In Vitro Predictions that Use Caco-2 as a Surrogate for Human Intestinal Permeability …
CA Larregieu, LZ Benet
The AAPS journal 15, 483-497, 2013
Mandates: US National Institutes of Health
Elucidating rifampin's inducing and inhibiting effects on glyburide pharmacokinetics and blood glucose in healthy volunteers: unmasking the differential effects of enzyme …
HX Zheng, Y Huang, LA Frassetto, LZ Benet
Clinical Pharmacology & Therapeutics 85 (1), 78-85, 2009
Mandates: US National Institutes of Health
The operational multiple dosing half-life: a key to defining drug accumulation in patients and to designing extended release dosage forms
S Sahin, LZ Benet
Pharmaceutical research 25, 2869-2877, 2008
Mandates: US National Institutes of Health
Predicting drug disposition via application of a biopharmaceutics drug disposition classification system
LZ Benet
Basic & clinical pharmacology & toxicology 106 (3), 162-167, 2010
Mandates: US National Institutes of Health
BDDCS class prediction for new molecular entities
F Broccatelli, G Cruciani, LZ Benet, TI Oprea
Molecular pharmaceutics 9 (3), 570-580, 2012
Mandates: US National Institutes of Health
Moringa oleifera leaf extracts inhibit 6β-hydroxylation of testosterone by CYP3A4
TG Monera, AR Wolfe, CC Maponga, LZ Benet, J Guglielmo
Journal of infection in developing countries 2 (5), 379, 2008
Mandates: US National Institutes of Health
Distinguishing between the permeability relationships with absorption and metabolism to improve BCS and BDDCS predictions in early drug discovery
CA Larregieu, LZ Benet
Molecular pharmaceutics 11 (4), 1335-1344, 2014
Mandates: US National Institutes of Health
An examination of protein binding and protein-facilitated uptake relating to in vitro-in vivo extrapolation
CM Bowman, LZ Benet
European Journal of Pharmaceutical Sciences 123, 502-514, 2018
Mandates: US National Science Foundation, US National Institutes of Health
Publication and funding information is determined automatically by a computer program